ESMO 2017: Combination Targeted Adjuvant Therapy Doubles Relapse-free Survival in Stage III Melanoma
Combination targeted adjuvant therapy with dabrafenib and trametinib doubles relapse-free survival in patients with stage…
Browsing: interferon
How new hepatitis C drugs could tackle liver cancer, too
Maryam Alavi, UNSW and Greg Dore, UNSW Wider availability of newer hepatitis C drugs may…
Interferon not beneficial for most stage III melanoma
Final results for the Sunbelt Melanoma Trial, published online this month in the Journal of Clinical…